vs
雅培(ABT)与林德(LIN)财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是林德的1.3倍($11.5B vs $8.8B),林德同比增速更快(8.2% vs 4.4%),雅培自由现金流更多($2.6B vs $898.0K),过去两年雅培的营收复合增速更高(7.2% vs 3.1%)
雅培是总部位于美国伊利诺伊州雅培园的跨国医疗健康企业,业务覆盖美国境外市场药品销售、诊断产品、营养产品及医疗器械等板块,在全球医疗健康领域拥有较高的行业知名度与广泛的市场覆盖。
林德是全球知名跨国化工企业,按市场份额及营收计为全球最大工业气体供应商。公司1879年由德国科学家、工程师卡尔·冯·林德在德国威斯巴登创立,现总部位于英国沃金,在爱尔兰注册,2018年由原林德股份公司与1907年在美国成立的普莱克斯合并组建。
ABT vs LIN — 直观对比
营收规模更大
ABT
是对方的1.3倍
$8.8B
营收增速更快
LIN
高出3.8%
4.4%
自由现金流更多
ABT
多$2.6B
$898.0K
两年增速更快
ABT
近两年复合增速
3.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $11.5B | $8.8B |
| 净利润 | $1.8B | — |
| 毛利率 | 57.0% | 48.5% |
| 营业利润率 | 19.6% | 27.8% |
| 净利率 | 15.5% | — |
| 营收同比 | 4.4% | 8.2% |
| 净利润同比 | -80.8% | — |
| 每股收益(稀释后) | $1.01 | $3.98 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ABT
LIN
| Q1 26 | — | $8.8B | ||
| Q4 25 | $11.5B | $8.8B | ||
| Q3 25 | $11.4B | $8.6B | ||
| Q2 25 | $11.1B | $8.5B | ||
| Q1 25 | $10.4B | $8.1B | ||
| Q4 24 | $11.0B | $8.3B | ||
| Q3 24 | $10.6B | $8.4B | ||
| Q2 24 | $10.4B | $8.3B |
净利润
ABT
LIN
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $1.6B | $1.9B | ||
| Q2 25 | $1.8B | $1.8B | ||
| Q1 25 | $1.3B | $1.7B | ||
| Q4 24 | $9.2B | $1.7B | ||
| Q3 24 | $1.6B | $1.6B | ||
| Q2 24 | $1.3B | $1.7B |
毛利率
ABT
LIN
| Q1 26 | — | 48.5% | ||
| Q4 25 | 57.0% | — | ||
| Q3 25 | 55.4% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 55.6% | — |
营业利润率
ABT
LIN
| Q1 26 | — | 27.8% | ||
| Q4 25 | 19.6% | 23.0% | ||
| Q3 25 | 18.1% | 27.5% | ||
| Q2 25 | 18.4% | 27.7% | ||
| Q1 25 | 16.3% | 26.9% | ||
| Q4 24 | 17.4% | 27.4% | ||
| Q3 24 | 17.5% | 25.0% | ||
| Q2 24 | 16.1% | 26.4% |
净利率
ABT
LIN
| Q1 26 | — | — | ||
| Q4 25 | 15.5% | 17.5% | ||
| Q3 25 | 14.5% | 22.4% | ||
| Q2 25 | 16.0% | 20.8% | ||
| Q1 25 | 12.8% | 20.6% | ||
| Q4 24 | 84.1% | 20.8% | ||
| Q3 24 | 15.5% | 18.5% | ||
| Q2 24 | 12.5% | 20.1% |
每股收益(稀释后)
ABT
LIN
| Q1 26 | — | $3.98 | ||
| Q4 25 | $1.01 | $3.28 | ||
| Q3 25 | $0.94 | $4.09 | ||
| Q2 25 | $1.01 | $3.73 | ||
| Q1 25 | $0.76 | $3.51 | ||
| Q4 24 | $5.26 | $3.61 | ||
| Q3 24 | $0.94 | $3.22 | ||
| Q2 24 | $0.74 | $3.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $8.9B | $4.0B |
| 总债务越低越好 | $12.9B | $24.7B |
| 股东权益账面价值 | $52.1B | $40.1B |
| 总资产 | $86.7B | $86.3B |
| 负债/权益比越低杠杆越低 | 0.25× | 0.62× |
8季度趋势,按日历期对齐
现金及短期投资
ABT
LIN
| Q1 26 | — | $4.0B | ||
| Q4 25 | $8.9B | $5.1B | ||
| Q3 25 | $7.7B | $4.5B | ||
| Q2 25 | $7.3B | $4.8B | ||
| Q1 25 | $6.8B | $5.3B | ||
| Q4 24 | $8.0B | $4.8B | ||
| Q3 24 | $7.8B | $5.2B | ||
| Q2 24 | $7.2B | $4.6B |
总债务
ABT
LIN
| Q1 26 | — | $24.7B | ||
| Q4 25 | $12.9B | $20.7B | ||
| Q3 25 | — | $18.6B | ||
| Q2 25 | — | $19.7B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | $14.1B | $15.3B | ||
| Q3 24 | — | $17.5B | ||
| Q2 24 | — | $16.9B |
股东权益
ABT
LIN
| Q1 26 | — | $40.1B | ||
| Q4 25 | $52.1B | $38.2B | ||
| Q3 25 | $51.0B | $38.6B | ||
| Q2 25 | $50.6B | $38.5B | ||
| Q1 25 | $48.8B | $38.0B | ||
| Q4 24 | $47.7B | $38.1B | ||
| Q3 24 | $39.8B | $39.2B | ||
| Q2 24 | $39.3B | $38.2B |
总资产
ABT
LIN
| Q1 26 | — | $86.3B | ||
| Q4 25 | $86.7B | $86.8B | ||
| Q3 25 | $84.2B | $86.0B | ||
| Q2 25 | $84.0B | $86.1B | ||
| Q1 25 | $81.4B | $82.7B | ||
| Q4 24 | $81.4B | $80.1B | ||
| Q3 24 | $74.4B | $82.5B | ||
| Q2 24 | $73.0B | $80.2B |
负债/权益比
ABT
LIN
| Q1 26 | — | 0.62× | ||
| Q4 25 | 0.25× | 0.54× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | 0.30× | 0.40× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | 0.44× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $3.3B | — |
| 自由现金流经营现金流 - 资本支出 | $2.6B | $898.0K |
| 自由现金流率自由现金流/营收 | 22.9% | 0.0% |
| 资本支出强度资本支出/营收 | 6.0% | — |
| 现金转化率经营现金流/净利润 | 1.87× | — |
| 过去12个月自由现金流最近4个季度 | $7.4B | $4.2B |
8季度趋势,按日历期对齐
经营现金流
ABT
LIN
| Q1 26 | — | — | ||
| Q4 25 | $3.3B | $3.0B | ||
| Q3 25 | $2.8B | $2.9B | ||
| Q2 25 | $2.0B | $2.2B | ||
| Q1 25 | $1.4B | $2.2B | ||
| Q4 24 | $2.9B | $2.8B | ||
| Q3 24 | $2.7B | $2.7B | ||
| Q2 24 | $2.0B | $1.9B |
自由现金流
ABT
LIN
| Q1 26 | — | $898.0K | ||
| Q4 25 | $2.6B | $1.6B | ||
| Q3 25 | $2.3B | $1.7B | ||
| Q2 25 | $1.5B | $954.0M | ||
| Q1 25 | $933.0M | $891.0M | ||
| Q4 24 | $2.1B | $1.6B | ||
| Q3 24 | $2.1B | $1.7B | ||
| Q2 24 | $1.4B | $796.0M |
自由现金流率
ABT
LIN
| Q1 26 | — | 0.0% | ||
| Q4 25 | 22.9% | 17.9% | ||
| Q3 25 | 20.2% | 19.4% | ||
| Q2 25 | 13.9% | 11.2% | ||
| Q1 25 | 9.0% | 11.0% | ||
| Q4 24 | 19.6% | 18.8% | ||
| Q3 24 | 20.2% | 19.9% | ||
| Q2 24 | 13.8% | 9.6% |
资本支出强度
ABT
LIN
| Q1 26 | — | — | ||
| Q4 25 | 6.0% | 16.6% | ||
| Q3 25 | 4.4% | 14.8% | ||
| Q2 25 | 4.5% | 14.8% | ||
| Q1 25 | 4.7% | 15.7% | ||
| Q4 24 | 6.6% | 15.1% | ||
| Q3 24 | 5.2% | 12.8% | ||
| Q2 24 | 5.1% | 13.7% |
现金转化率
ABT
LIN
| Q1 26 | — | — | ||
| Q4 25 | 1.87× | 1.98× | ||
| Q3 25 | 1.70× | 1.53× | ||
| Q2 25 | 1.15× | 1.25× | ||
| Q1 25 | 1.07× | 1.29× | ||
| Q4 24 | 0.31× | 1.63× | ||
| Q3 24 | 1.64× | 1.76× | ||
| Q2 24 | 1.51× | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图